There are complications for oral administration due to the protein being digested in the gut before it is able to act systemically as an antioxidant enzyme, so further understanding of the role of SOD-2 function, in reducing OS in humans needs to be better defined, especially in relation to neurodegenerative disorders like AD. The gene discussed is SOD2; the disease is Alzheimer disease.